APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxaliplatin

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

Selected research

Market Structure

Global Oxaliplatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchOxaliplatin Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxaliplatin Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Oxaliplatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxaliplatin Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxaliplatin Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

Read the full market overview

The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

Report Includes

This report provides an overview of the global Oxaliplatin market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxaliplatin and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxaliplatin revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oxaliplatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxaliplatin Segment by Company

Sanofi-Aventis

Yakult honsha

Dr Reddy's laboratories

Sun Pharmaceutical

Teva

Fresenius Kabi

Hospira

Mylan

Jiangsu Hengrui Medicine

Nanjing Pharmaceutical Factory

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Hisun Pharmaceutical

Lunan Pharmaceutical

Luoxin

Halfsky Pharmacy

YRPG

Hainan Jinrui Pharmaceutical

Jari Pharmaceutical

Chiatai Tianqing

Oxaliplatin Segment by Type

Mannitol

Glucose Solution

Lactose Solution

Others

Oxaliplatin Segment by Application

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Others

Oxaliplatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxaliplatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxaliplatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxaliplatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oxaliplatin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oxaliplatin industry.

Chapter 3: Detailed analysis of Oxaliplatin companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxaliplatinrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Mannitol Table 3. Key Players of Glucose Solution Table 4. Key Players of Lactose Solution Table 3. Key Players of Others Table 4. Global Oxaliplatin Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Colorectal Cancer Table 6. Key Players of Stomach Cancer Table 7. Key Players of Ovarian Cancer Table 8. Key Players of Others Table 9. Global Oxaliplatin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Oxaliplatin Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Oxaliplatin Market Share by Region (2021-2026) Table 12. Global Oxaliplatin Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Oxaliplatin Market Share by Region (2027-2032) Table 14. Oxaliplatin Industry Trends Table 15. Oxaliplatin Industry Drivers Table 16. Oxaliplatin Industry Opportunities and Challenges Table 17. Oxaliplatin Industry Restraints Table 18. Global Oxaliplatin Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Oxaliplatin Revenue Market Share by Company (2021-2026) Table 20. Global Oxaliplatin Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Oxaliplatin Key Company Head Office and Area Served Table 22. Global Oxaliplatin Company, Product Type & Application Table 23. Global Oxaliplatin Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Oxaliplatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Oxaliplatin Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Oxaliplatin Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Oxaliplatin Revenue Market Share by Type (2021-2026) Table 30. Global Oxaliplatin Revenue Market Share by Type (2027-2032) Table 31. Global Oxaliplatin Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Oxaliplatin Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Oxaliplatin Revenue Market Share by Application (2021-2026) Table 35. Global Oxaliplatin Revenue Market Share by Application (2027-2032) Table 36. Sanofi-Aventis Company Information Table 37. Sanofi-Aventis Business Overview Table 38. Sanofi-Aventis Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sanofi-Aventis Oxaliplatin Product Portfolio Table 40. Sanofi-Aventis Recent Development Table 41. Yakult honsha Company Information Table 42. Yakult honsha Business Overview Table 43. Yakult honsha Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Yakult honsha Oxaliplatin Product Portfolio Table 45. Yakult honsha Recent Development Table 46. Dr Reddy's laboratories Company Information Table 47. Dr Reddy's laboratories Business Overview Table 48. Dr Reddy's laboratories Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Dr Reddy's laboratories Oxaliplatin Product Portfolio Table 50. Dr Reddy's laboratories Recent Development Table 51. Sun Pharmaceutical Company Information Table 52. Sun Pharmaceutical Business Overview Table 53. Sun Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Sun Pharmaceutical Oxaliplatin Product Portfolio Table 55. Sun Pharmaceutical Recent Development Table 56. Teva Company Information Table 57. Teva Business Overview Table 58. Teva Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Teva Oxaliplatin Product Portfolio Table 60. Teva Recent Development Table 61. Fresenius Kabi Company Information Table 62. Fresenius Kabi Business Overview Table 63. Fresenius Kabi Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Fresenius Kabi Oxaliplatin Product Portfolio Table 65. Fresenius Kabi Recent Development Table 66. Hospira Company Information Table 67. Hospira Business Overview Table 68. Hospira Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Hospira Oxaliplatin Product Portfolio Table 70. Hospira Recent Development Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Mylan Oxaliplatin Product Portfolio Table 75. Mylan Recent Development Table 76. Jiangsu Hengrui Medicine Company Information Table 77. Jiangsu Hengrui Medicine Business Overview Table 78. Jiangsu Hengrui Medicine Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Jiangsu Hengrui Medicine Oxaliplatin Product Portfolio Table 80. Jiangsu Hengrui Medicine Recent Development Table 81. Nanjing Pharmaceutical Factory Company Information Table 82. Nanjing Pharmaceutical Factory Business Overview Table 83. Nanjing Pharmaceutical Factory Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio Table 85. Nanjing Pharmaceutical Factory Recent Development Table 86. Jiangsu Aosaikang Pharmaceutical Company Information Table 87. Jiangsu Aosaikang Pharmaceutical Business Overview Table 88. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Portfolio Table 90. Jiangsu Aosaikang Pharmaceutical Recent Development Table 91. Qilu Pharmaceutical Company Information Table 92. Qilu Pharmaceutical Business Overview Table 93. Qilu Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Qilu Pharmaceutical Oxaliplatin Product Portfolio Table 95. Qilu Pharmaceutical Recent Development Table 96. Hisun Pharmaceutical Company Information Table 97. Hisun Pharmaceutical Business Overview Table 98. Hisun Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Hisun Pharmaceutical Oxaliplatin Product Portfolio Table 100. Hisun Pharmaceutical Recent Development Table 101. Lunan Pharmaceutical Company Information Table 102. Lunan Pharmaceutical Business Overview Table 103. Lunan Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Lunan Pharmaceutical Oxaliplatin Product Portfolio Table 105. Lunan Pharmaceutical Recent Development Table 106. Luoxin Company Information Table 107. Luoxin Business Overview Table 108. Luoxin Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Luoxin Oxaliplatin Product Portfolio Table 110. Luoxin Recent Development Table 111. Halfsky Pharmacy Company Information Table 112. Halfsky Pharmacy Business Overview Table 113. Halfsky Pharmacy Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Halfsky Pharmacy Oxaliplatin Product Portfolio Table 115. Halfsky Pharmacy Recent Development Table 116. YRPG Company Information Table 117. YRPG Business Overview Table 118. YRPG Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. YRPG Oxaliplatin Product Portfolio Table 120. YRPG Recent Development Table 121. Hainan Jinrui Pharmaceutical Company Information Table 122. Hainan Jinrui Pharmaceutical Business Overview Table 123. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Hainan Jinrui Pharmaceutical Oxaliplatin Product Portfolio Table 125. Hainan Jinrui Pharmaceutical Recent Development Table 126. Jari Pharmaceutical Company Information Table 127. Jari Pharmaceutical Business Overview Table 128. Jari Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Jari Pharmaceutical Oxaliplatin Product Portfolio Table 130. Jari Pharmaceutical Recent Development Table 131. Chiatai Tianqing Company Information Table 132. Chiatai Tianqing Business Overview Table 133. Chiatai Tianqing Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Chiatai Tianqing Oxaliplatin Product Portfolio Table 135. Chiatai Tianqing Recent Development Table 136. North America Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 137. North America Oxaliplatin Market Size by Type (2027-2032) & (US$ Million) Table 138. North America Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 139. North America Oxaliplatin Market Size by Application (2027-2032) & (US$ Million) Table 140. North America Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Oxaliplatin Market Size by Country (2021-2026) Table 142. North America Oxaliplatin Market Size by Country (2027-2032) Table 143. Europe Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 144. Europe Oxaliplatin Market Size by Type (2027-2032) & (US$ Million) Table 145. Europe Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 146. Europe Oxaliplatin Market Size by Application (2027-2032) & (US$ Million) Table 147. Europe Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Oxaliplatin Market Size by Country (2021-2026) Table 149. Europe Oxaliplatin Market Size by Country (2027-2032) Table 150. China Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 151. China Oxaliplatin Market Size by Type (2027-2032) & (US$ Million) Table 152. China Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 153. China Oxaliplatin Market Size by Application (2027-2032) & (US$ Million) Table 154. Asia Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 155. Asia Oxaliplatin Market Size by Type (2027-2032) & (US$ Million) Table 156. Asia Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 157. Asia Oxaliplatin Market Size by Application (2027-2032) & (US$ Million) Table 158. Asia Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Oxaliplatin Market Size by Country (2021-2026) Table 160. Asia Oxaliplatin Market Size by Country (2027-2032) Table 161. South America, Middle East & Africa Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 162. South America, Middle East & Africa Oxaliplatin Market Size by Type (2027-2032) & (US$ Million) Table 163. South America, Middle East & Africa Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 164. South America, Middle East & Africa Oxaliplatin Market Size by Application (2027-2032) & (US$ Million) Table 165. South America, Middle East & Africa Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. South America, Middle East & Africa Oxaliplatin Market Size by Country (2021-2026) Table 167. South America, Middle East & Africa Oxaliplatin Market Size by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Oxaliplatin Product Image Figure 2. Global Oxaliplatin Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oxaliplatin Market Share by Type: 2025 VS 2032 Figure 4. Mannitol Image Figure 5. Glucose Solution Image Figure 6. Lactose Solution Image Figure 7. Others Image Figure 8. Global Oxaliplatin Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Oxaliplatin Market Share by Application: 2025 VS 2032 Figure 10. Colorectal Cancer Image Figure 11. Stomach Cancer Image Figure 12. Ovarian Cancer Image Figure 13. Others Image Figure 14. Global Oxaliplatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 16. Global Oxaliplatin Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Oxaliplatin Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Oxaliplatin Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Oxaliplatin Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Oxaliplatin Revenue Market Share by Type (2021-2032) Figure 23. Global Oxaliplatin Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Oxaliplatin Revenue Market Share by Application (2021-2032) Figure 25. North America Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 26. North America Oxaliplatin Market Share by Type (2021-2032) Figure 27. North America Oxaliplatin Market Share by Application (2021-2032) Figure 28. North America Oxaliplatin Market Share by Country (2021-2032) Figure 29. United States Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 30. Canada Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 32. Europe Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 33. Europe Oxaliplatin Market Share by Type (2021-2032) Figure 34. Europe Oxaliplatin Market Share by Application (2021-2032) Figure 35. Europe Oxaliplatin Market Share by Country (2021-2032) Figure 36. Germany Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 37. France Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 39. Italy Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 40. Russia Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 42. China Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 43. China Oxaliplatin Market Share by Type (2021-2032) Figure 44. China Oxaliplatin Market Share by Application (2021-2032) Figure 45. Asia Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 46. Asia Oxaliplatin Market Share by Type (2021-2032) Figure 47. Asia Oxaliplatin Market Share by Application (2021-2032) Figure 48. Asia Oxaliplatin Market Share by Country (2021-2032) Figure 49. Japan Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 53. India Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 54. Australia Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Oxaliplatin Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Oxaliplatin Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Oxaliplatin Market Share by Country (2021-2032) Figure 59. Brazil Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 64. UAE Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 66. Chile Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Others
Applications
  • Colorectal Cancer
  • Stomach Cancer
  • Ovarian Cancer
  • Others
Companies covered
  • Sanofi-Aventis
  • Yakult honsha
  • Dr Reddy's laboratories
  • Sun Pharmaceutical
  • Teva
  • Fresenius Kabi
  • Hospira
  • Mylan
  • Jiangsu Hengrui Medicine
  • Nanjing Pharmaceutical Factory
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Hisun Pharmaceutical
  • Lunan Pharmaceutical
  • Luoxin
  • Halfsky Pharmacy
  • YRPG
  • Hainan Jinrui Pharmaceutical
  • Jari Pharmaceutical
  • Chiatai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oxaliplatin Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Mannitol
  5. 1.2.3 Glucose Solution
  6. 1.2.4 Lactose Solution
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Oxaliplatin Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Colorectal Cancer
  11. 1.3.3 Stomach Cancer
  12. 1.3.4 Ovarian Cancer
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Oxaliplatin Growth Trends by Region
  16. 1.5.1 Global Oxaliplatin Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Oxaliplatin Market Size by Region (2021-2026)
  18. 1.5.3 Oxaliplatin Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Oxaliplatin Market Dynamics
  1. 2.1 Oxaliplatin Industry Trends
  2. 2.2 Oxaliplatin Industry Drivers
  3. 2.3 Oxaliplatin Industry Opportunities and Challenges
  4. 2.4 Oxaliplatin Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oxaliplatin Revenue by Company (2021-2026)
  2. 3.2 Global Oxaliplatin Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oxaliplatin Key Company Head office and Area Served
  4. 3.4 Global Oxaliplatin Company, Product Type & Application
  5. 3.5 Global Oxaliplatin Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oxaliplatin Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oxaliplatin Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oxaliplatin Tier 1, Tier 2, and Tier 3
4 Oxaliplatin Market by Type
  1. 4.1 Global Oxaliplatin Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oxaliplatin Market Size by Type (2021-2032)
  3. 4.3 Global Oxaliplatin Market Size Share by Type (2021-2032)
5 Oxaliplatin Market by Application
  1. 5.1 Global Oxaliplatin Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oxaliplatin Market Size by Application (2021-2032)
  3. 5.3 Global Oxaliplatin Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi-Aventis
  2. 6.1.1 Sanofi-Aventis Company Information
  3. 6.1.2 Sanofi-Aventis Business Overview
  4. 6.1.3 Sanofi-Aventis Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi-Aventis Oxaliplatin Product Portfolio
  6. 6.1.5 Sanofi-Aventis Recent Developments
  7. 6.2 Yakult honsha
  8. 6.2.1 Yakult honsha Company Information
  9. 6.2.2 Yakult honsha Business Overview
  10. 6.2.3 Yakult honsha Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Yakult honsha Oxaliplatin Product Portfolio
  12. 6.2.5 Yakult honsha Recent Developments
  13. 6.3 Dr Reddy's laboratories
  14. 6.3.1 Dr Reddy's laboratories Company Information
  15. 6.3.2 Dr Reddy's laboratories Business Overview
  16. 6.3.3 Dr Reddy's laboratories Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Dr Reddy's laboratories Oxaliplatin Product Portfolio
  18. 6.3.5 Dr Reddy's laboratories Recent Developments
  19. 6.4 Sun Pharmaceutical
  20. 6.4.1 Sun Pharmaceutical Company Information
  21. 6.4.2 Sun Pharmaceutical Business Overview
  22. 6.4.3 Sun Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sun Pharmaceutical Oxaliplatin Product Portfolio
  24. 6.4.5 Sun Pharmaceutical Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Teva Oxaliplatin Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Fresenius Kabi Oxaliplatin Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 Hospira
  38. 6.7.1 Hospira Company Information
  39. 6.7.2 Hospira Business Overview
  40. 6.7.3 Hospira Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Hospira Oxaliplatin Product Portfolio
  42. 6.7.5 Hospira Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Mylan Oxaliplatin Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Jiangsu Hengrui Medicine
  50. 6.9.1 Jiangsu Hengrui Medicine Company Information
  51. 6.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 6.9.3 Jiangsu Hengrui Medicine Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Jiangsu Hengrui Medicine Oxaliplatin Product Portfolio
  54. 6.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 6.10 Nanjing Pharmaceutical Factory
  56. 6.10.1 Nanjing Pharmaceutical Factory Company Information
  57. 6.10.2 Nanjing Pharmaceutical Factory Business Overview
  58. 6.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio
  60. 6.10.5 Nanjing Pharmaceutical Factory Recent Developments
  61. 6.11 Jiangsu Aosaikang Pharmaceutical
  62. 6.11.1 Jiangsu Aosaikang Pharmaceutical Company Information
  63. 6.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  64. 6.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Portfolio
  66. 6.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  67. 6.12 Qilu Pharmaceutical
  68. 6.12.1 Qilu Pharmaceutical Company Information
  69. 6.12.2 Qilu Pharmaceutical Business Overview
  70. 6.12.3 Qilu Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Qilu Pharmaceutical Oxaliplatin Product Portfolio
  72. 6.12.5 Qilu Pharmaceutical Recent Developments
  73. 6.13 Hisun Pharmaceutical
  74. 6.13.1 Hisun Pharmaceutical Company Information
  75. 6.13.2 Hisun Pharmaceutical Business Overview
  76. 6.13.3 Hisun Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Hisun Pharmaceutical Oxaliplatin Product Portfolio
  78. 6.13.5 Hisun Pharmaceutical Recent Developments
  79. 6.14 Lunan Pharmaceutical
  80. 6.14.1 Lunan Pharmaceutical Company Information
  81. 6.14.2 Lunan Pharmaceutical Business Overview
  82. 6.14.3 Lunan Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Lunan Pharmaceutical Oxaliplatin Product Portfolio
  84. 6.14.5 Lunan Pharmaceutical Recent Developments
  85. 6.15 Luoxin
  86. 6.15.1 Luoxin Company Information
  87. 6.15.2 Luoxin Business Overview
  88. 6.15.3 Luoxin Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Luoxin Oxaliplatin Product Portfolio
  90. 6.15.5 Luoxin Recent Developments
  91. 6.16 Halfsky Pharmacy
  92. 6.16.1 Halfsky Pharmacy Company Information
  93. 6.16.2 Halfsky Pharmacy Business Overview
  94. 6.16.3 Halfsky Pharmacy Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Halfsky Pharmacy Oxaliplatin Product Portfolio
  96. 6.16.5 Halfsky Pharmacy Recent Developments
  97. 6.17 YRPG
  98. 6.17.1 YRPG Company Information
  99. 6.17.2 YRPG Business Overview
  100. 6.17.3 YRPG Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 YRPG Oxaliplatin Product Portfolio
  102. 6.17.5 YRPG Recent Developments
  103. 6.18 Hainan Jinrui Pharmaceutical
  104. 6.18.1 Hainan Jinrui Pharmaceutical Company Information
  105. 6.18.2 Hainan Jinrui Pharmaceutical Business Overview
  106. 6.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Product Portfolio
  108. 6.18.5 Hainan Jinrui Pharmaceutical Recent Developments
  109. 6.19 Jari Pharmaceutical
  110. 6.19.1 Jari Pharmaceutical Company Information
  111. 6.19.2 Jari Pharmaceutical Business Overview
  112. 6.19.3 Jari Pharmaceutical Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Jari Pharmaceutical Oxaliplatin Product Portfolio
  114. 6.19.5 Jari Pharmaceutical Recent Developments
  115. 6.20 Chiatai Tianqing
  116. 6.20.1 Chiatai Tianqing Company Information
  117. 6.20.2 Chiatai Tianqing Business Overview
  118. 6.20.3 Chiatai Tianqing Oxaliplatin Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Chiatai Tianqing Oxaliplatin Product Portfolio
  120. 6.20.5 Chiatai Tianqing Recent Developments
7 North America
  1. 7.1 North America Oxaliplatin Market Size (2021-2032)
  2. 7.2 North America Oxaliplatin Market Size by Type
  3. 7.2.1 North America Oxaliplatin Market Size by Type (2021-2026)
  4. 7.2.2 North America Oxaliplatin Market Size by Type (2027-2032)
  5. 7.2.3 North America Oxaliplatin Market Share by Type (2021-2032)
  6. 7.3 North America Oxaliplatin Market Size by Application
  7. 7.3.1 North America Oxaliplatin Market Size by Application (2021-2026)
  8. 7.3.2 North America Oxaliplatin Market Size by Application (2027-2032)
  9. 7.3.3 North America Oxaliplatin Market Share by Application (2021-2032)
  10. 7.4 North America Oxaliplatin Market Size by Country
  11. 7.4.1 North America Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oxaliplatin Market Size by Country (2021-2026)
  13. 7.4.3 North America Oxaliplatin Market Size by Country (2027-2032)
  14. 7.4.4 North America Oxaliplatin Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oxaliplatin Market Size (2021-2032)
  2. 8.2 Europe Oxaliplatin Market Size by Type
  3. 8.2.1 Europe Oxaliplatin Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oxaliplatin Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oxaliplatin Market Share by Type (2021-2032)
  6. 8.3 Europe Oxaliplatin Market Size by Application
  7. 8.3.1 Europe Oxaliplatin Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oxaliplatin Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oxaliplatin Market Share by Application (2021-2032)
  10. 8.4 Europe Oxaliplatin Market Size by Country
  11. 8.4.1 Europe Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oxaliplatin Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oxaliplatin Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oxaliplatin Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oxaliplatin Market Size (2021-2032)
  2. 9.2 China Oxaliplatin Market Size by Type
  3. 9.2.1 China Oxaliplatin Market Size by Type (2021-2026)
  4. 9.2.2 China Oxaliplatin Market Size by Type (2027-2032)
  5. 9.2.3 China Oxaliplatin Market Share by Type (2021-2032)
  6. 9.3 China Oxaliplatin Market Size by Application
  7. 9.3.1 China Oxaliplatin Market Size by Application (2021-2026)
  8. 9.3.2 China Oxaliplatin Market Size by Application (2027-2032)
  9. 9.3.3 China Oxaliplatin Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oxaliplatin Market Size (2021-2032)
  2. 10.2 Asia Oxaliplatin Market Size by Type
  3. 10.2.1 Asia Oxaliplatin Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oxaliplatin Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oxaliplatin Market Share by Type (2021-2032)
  6. 10.3 Asia Oxaliplatin Market Size by Application
  7. 10.3.1 Asia Oxaliplatin Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oxaliplatin Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oxaliplatin Market Share by Application (2021-2032)
  10. 10.4 Asia Oxaliplatin Market Size by Country
  11. 10.4.1 Asia Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oxaliplatin Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oxaliplatin Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oxaliplatin Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oxaliplatin Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oxaliplatin Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oxaliplatin Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oxaliplatin Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oxaliplatin Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oxaliplatin Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oxaliplatin Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oxaliplatin Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oxaliplatin Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oxaliplatin Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oxaliplatin Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oxaliplatin Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oxaliplatin Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oxaliplatin Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst